Exploring a new therapy approach for depression and anxiety
Feasibility of Process-based Therapy in a Naturalistic Setting
This study is testing a new therapy approach for depression and anxiety to see if it works better than usual methods when used by therapists in real-life settings.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Goethe University Academic / other |
| Locations | 1 site (Frankfurt am Main, Hessen) |
| Trial ID | NCT06530888 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility of Process-based Therapy (PBT) in a natural mental health care setting, where practitioners typically rely on established theories and personal experience for treatment decisions. PBT emphasizes the use of empirical data and rational criteria to tailor interventions, utilizing ecological momentary assessment and dynamic network analysis to inform treatment. The study aims to determine whether PBT can be effectively implemented by psychotherapists and to compare its acceptability and efficacy against routine psychotherapy practices. By focusing on real-world applications, the research seeks to provide insights into the practical use of PBT in treating depressive and anxiety disorders.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with a primary diagnosis of depressive or anxiety disorders who can communicate in German.
Not a fit: Patients with severe mental health issues such as suicidality, substance abuse, or certain personality disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance treatment outcomes for patients with depression and anxiety by providing more personalized and evidence-based therapy options.
How similar studies have performed: While the specific approach of Process-based Therapy is novel, similar studies exploring empirical and individualized treatment methods have shown promise in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A primary DSM-5 diagnosis of a depressive or anxiety disorder * Age 18-65 years * Sufficient knowledge of the German language * Participating patients are not required to discontinue medication, but to keep medication constant over the treatment period Exclusion Criteria: * Increased suicidality * Substance abuse or dependency * Diagnose of a cluster A or B (DSM-5) personality disorder * Pervasive developmental disorder * Psychotic disorder * Eating disorder * Bipolar disorder * Severe physical illness
Where this trial is running
Frankfurt am Main, Hessen
- JWGUniversity — Frankfurt am Main, Hessen, Germany (Recruiting)
Study contacts
- Study coordinator: Ulrich Stangier, PhD
- Email: stangier@psych.uni-frankfurt.de
- Phone: 049 1707339293
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.